Down-regulation of Fas gene expression in colon cancer is not a result of allelic loss or gene rearrangement
1998

Fas Gene Expression in Colon Cancer

Sample size: 88 publication Evidence: moderate

Author Information

Author(s): LM Butler, PJ Hewett, WJ Butler, PA Cowled

Primary Institution: The University of Adelaide, The Queen Elizabeth Hospital

Hypothesis

Is the down-regulation of Fas gene expression in colon cancer due to allelic loss or gene rearrangement?

Conclusion

The study found that the loss of Fas protein expression in colon cancer is not primarily due to disruptions in the Fas gene.

Supporting Evidence

  • Fas expression was reduced or absent in 7 of 11 tumors from informative patients without LOH.
  • Six of the 38 informative tumors exhibited partial allelic loss at the Fas locus.
  • Three patients with LOH did not express detectable Fas mRNA.

Takeaway

This study looked at a gene called Fas that helps cells die when they are damaged. In colon cancer, this gene doesn't work well, but it's not because the gene is missing or broken.

Methodology

The study used PCR to analyze the Fas gene for loss of heterozygosity and Southern blotting to check for gene rearrangements in colon tumors.

Limitations

The study had a small number of patients with allelic loss, limiting the ability to draw broader conclusions.

Participant Demographics

Patients undergoing surgical colonic resections, including 38 informative patients with colon carcinomas.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication